(Press-News.org) Information is lacking on most implanted medical devices cleared by the U.S. Food and Drug Administration despite a legal requirement that companies submit scientific evidence about the devices' substantial equivalence to other devices already on the market.
Under what is known as the 510(k) review, the FDA clears about 400 implanted medical devices without clinical testing each year for market that are considered moderate to high risk. The FDA has a process that requires the applicant to provide scientific evidence that the new device is "substantially equivalent" to devices already on the market. The companies are legally required to submit the evidence to the FDA and to make publicly available at least a summary of the evidence.
The authors examined what kind of evidence companies submitted about their devices and whether it was publicly available by using FDA databases. The authors identified the first two implanted medical devices approved in each of five categories for each year from 2008 through 2012, and their sample of 50 devices included total hip implants, vascular embolization devices and surgical mesh. They also identified 1,105 "predicates," or devices already on the market, that companies listed for their devices.
Scientific data to support a claim of substantial equivalence were publicly available for 8 of the 50 (16 percent) newly cleared implants and 31 of their 1,105 (3 percent) predicate devices. Most of the evidence was nonclinical data and some of it also evaluated the safety or effectiveness of the devices.
Discussion: "For implants cleared between 2008 and 2012, however, we repeatedly found that scientific evidence of the substantial equivalence, safety or effectiveness of medical devices was not publicly available in accordance with the legal requirements. To protect the public health and allow for independent judgment of the quality of the scientific evidence that supports the marketing of medical devices, the FDA should enforce the law."
Author: Diana Zuckerman, Ph.D, of the National Center for Health Research, Washington, and colleagues.
(JAMA Intern Med. Published online September 29, 2014. doi:10.1001/jamainternmed.2014.4193. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor's Note: Support for the project was provided by The Pew Charitable Trusts and by donations to the Center for Health Research. An author made a funding disclosure. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Post-Approval Studies to Assess Safety, Efficacy of Devices After FDA OK
Small sample sizes and delays on agreement of protocol may hinder the clinical usefulness of post-approval studies (PASs) on medical devices ordered by the FDA.
Post-market surveillance is part of evaluating the safety and effectiveness of medical devices, which typically are approved by the FDA with less clinical data than medications. One of the FDAs most important tools to do this surveillance of high-risk devices is to order PASs. The FDA has ordered hundreds of these over the past decade but a systematic evaluation of the program has not been published. The authors examined the number and characteristics of PASs ordered by the agency.
The authors gathered information from the FDA website, which is the publicly available source of information on PASs.
Between January 2005 and December 2011, the FDA ordered 223 studies of 158 medical devices, including studies for 93 (48 percent) new high-risk devices that were approved. The median required sample size for a study was 350 patients. If a study protocol was not in place when the device was approved, a median of 180 days passed before a protocol could be agreed upon. The FDA has never issued a warning letter or a penalty because of study delays, lack of progress or any other issue related to a PAS. The most common result of a PAS finding after the study was completed was that the FDA requested a labeling change for 31 studies (53 percent). The FDA included indepth information on the PASs website for 54 of 58 completed studies (93 percent).
"Given our findings – in particular, that only 1 of 223 studies has resulted in any action other than a labeling change – we encourage the agency to work together with all stakeholders to evaluate how these studies can more effectively be used to improve the public health."
Author: Ian S. Reynolds, M.P.H., of The Pew Charitable Trusts, Washington, and colleagues.
(JAMA Intern Med. Published online September 29, 2014. doi:10.1001/jamainternmed.2014.4194. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor's Note: The authors made conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Commentary: Improving Medical Device Regulation, Work in Progress
In a related commentary, Elisabeth M. Dietrich, M.P.H., of the University of California, San Francisco, and Joshua M. Sharfstein, M.D., of the Maryland Department of Health and Mental Hygiene, Baltimore, write: "The mission of the FDA is to protect the public health by providing reasonable assurance that marketed medical devices are safe and effective and to promote the public health by streamlining regulatory processes and eliminating unnecessary barriers to medical device innovation. At times, the agency has rightfully been criticized for pursuing one goal at the expense of the other. In recent years, the FDA's Center for Devices and Radiological Health has been actively undertaking reforms to advance both goals simultaneously and to improve the scientific rigor of its operations. It is important to recognize and support this progress, even as the FDA's performance continues to be monitored through research and oversight."
(JAMA Intern Med. Published online September 29, 2014. doi:10.1001/jamainternmed.2014.3211. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor's Note: The authors made conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Viewpoint: The FDA's Unique Device Identification System, Better Postmarket Data on the Safety and Effectiveness of Medical Devices by Josh Rising, M.D., M.P.H., and Ben Moscovitch, M.A., of the Pew Charitable Trusts, Washington, also was published.
INFORMATION:
Media Advisory: To contact author Diana Zuckerman, Ph.D., call 202-223-4000 or email dz@center4research.org. To contact author Ian S. Reynolds call Erin W. Davis 202-540-6677 or email edavis@pewtrusts.org. To contact commentary author Joshua Sharfstein, M.D., call Christopher Garrett at 410-767-3536 or email christopher.garrett@maryland.gov. A podcast with Drs. Zuckerman and Sharfstein will be available when the embargo lifts on the JAMA Internal Medicine website: http://bit.ly/IZGqPC
Study finds information lacking from FDA on implanted medical devices
2014-09-29
ELSE PRESS RELEASES FROM THIS DATE:
AAN: Risks of opioids outweigh benefits for headache, low back pain, other conditions
2014-09-29
MINNEAPOLIS – According to a new position statement from the American Academy of Neurology (AAN), the risk of death, overdose, addiction or serious side effects with prescription opioids outweigh the benefits in chronic, non-cancer conditions such as headache, fibromyalgia and chronic low back pain. The position paper is published in the September 30, 2014, print issue of Neurology®, the medical journal of the American Academy of Neurology.
Opioids, or narcotics, are pain medications including morphine, codeine, oxycodone, methadone, fentanyl, hydrocodone or a combination ...
Use of broad-spectrum antibiotics before age 2 associated with obesity risk
2014-09-29
Bottom Line: The use of broad-spectrum antibiotics by children before the age of 24 months was associated with increased risk of obesity in early childhood.
Author: L. Charles Bailey, M.D., Ph.D., of the Children's Hospital of Philadelphia, and colleagues.
Background: Obesity is a major public health problem. Previous research suggests intestinal microflora may be associated with obesity, and antibiotic exposure may affect microbial diversity and composition.
How the Study Was Conducted: The authors used electronic health records spanning from 2001 to 2013 from ...
Healthy fats help diseased heart muscle process and use fuel
2014-09-29
Oleate, a common dietary fat found in olive oil, restored proper metabolism of fuel in an animal model of heart failure.
The findings are reported in the journal Circulation by researchers at University of Illinois at Chicago College of Medicine.
Heart failure affects nearly 5 million Americans, and more than half a million new cases are diagnosed each year. Heart failure is not the same as having a heart attack -- it is a chronic disease state where the heart becomes enlarged, or hypertrophic, in response to chronic high blood pressure which requires it to work harder ...
BUSM researchers identify brain changes involved in alcohol-related sleep disturbances
2014-09-29
(Boston) – A review article published online in Behavioral Brain Research provides novel insight into changes that happen in the brain as a result of chronic alcohol exposure that can lead to disruptions in the sleep cycle.
Clinical assessments and research indicate that individuals with alcohol use disorders frequently suffer from severely disrupted sleep. This can occur when people are actively drinking, when they are going through withdrawal or when they are abstaining.
"Sleep-wake disturbances can last for months, or even years, after someone stops drinking, which ...
Glaciers in the Grand Canyon of Mars?
2014-09-29
Boulder, Colo., USA – For decades, planetary geologists have speculated that glaciers might once have crept through Valles Marineris, the 2000-mile-long chasm that constitutes the Grand Canyon of Mars. Using satellite images, researchers have identified features that might have been carved by past glaciers as they flowed through the canyons; however, these observations have remained highly controversial and contested.
Now, a joint team from Bryn Mawr College and the Freie Universitaet Berlin has identified what could be the first mineralogical evidence of past glaciers ...
At the interface of math and science
2014-09-29
In popular culture, mathematics is often deemed inaccessible or esoteric. Yet in the modern world, it plays an ever more important role in our daily lives and a decisive role in the discovery and development of new ideas — often behind the scenes.
UC Santa Barbara's Paul Atzberger, a professor in the Department of Mathematics and an assistant professor of mechanical engineering, often works in areas where science and math intersect. Some of his recent research published in the Proceedings of the National Academy of Science (PNAS) and featured on the cover of the journal ...
Newborn Tropical Storm Phanfone triggers warnings in Northwestern Pacific
2014-09-29
NASA's Aqua satellite passed over newborn Tropical Storm Phanfone on Sept. 29 and captured a picture of the storm that showed thunderstorms wrapped tightly around the storm's center, and a large band of thunderstorms spiraling into the center from the east. Phanfone is now a threat to various islands and warnings are in effect.
A tropical storm Warning is in effect for Saipan, Tinian, Pagan and Alamagan. In addition, a typhoon watch is in effect for the northern Marianas Islands, including Pagan and Alamagan.
The Moderate Resolution Imaging Spectroradiometer (MODIS) ...
NASA sees Tropical Storm Kammuri winding down over open ocean
2014-09-29
Tropical Storm Kammuri continues to appear more like a cold front on satellite imagery as it transitions into an extra-tropical storm over the Northwestern Pacific Ocean.
When NASA's Terra satellite passed over Kammuri on Sept. 29 at 7:40 a.m. EDT (11:40 UTC), the Moderate Resolution Imaging Spectroradiometer or MODIS instrument captured an infrared look at the storm. MODIS showed that the bulk of strong storms elongated from southwest to northeast.
On Sept. 29, 2014 at 0300 UTC (Sept. 28 at 11 p.m. EDT) Tropical Storm Kammuri had maximum sustained winds near 45 knots ...
NASA's Aqua satellite sees Rachel before losing hurricane status
2014-09-29
Tropical Storm Rachel strengthened into a hurricane over the weekend of Sept. 27 and 28, only to weaken back into a tropical storm by Sept. 29. NASA's Aqua satellite passed over Rachel before it weakened and took a visible picture of the storm off Baja California's coast.
Rachel became the Eastern Pacific Ocean's twelfth hurricane on Saturday, Sept. 27 at 5 p.m. EDT when maximum sustained winds reached 75 mph (120 kph). When NASA's Aqua satellite saw Rachel, the maximum sustained winds were at the same strength. At that time, Rachel's center was 485 miles (780 km) west ...
MaxBin: Automated sorting through metagenomes
2014-09-29
Microbes – the single-celled organisms that dominate every ecosystem on Earth - have an amazing ability to feed on plant biomass and convert it into other chemical products. Tapping into this talent has the potential to revolutionize energy, medicine, environmental remediation and many other fields. The success of this effort hinges in part on metagenomics, the emerging technology that enables researchers to read all the individual genomes of a sample microbial community at once. However, given that even a teaspoon of soil can contain billions of microbes, there is a great ...